FDA Inspection 1017569 — Los Angeles General Medical Center

Los Angeles General Medical Center — FEI 2015676

The FDA completed an inspection of Los Angeles General Medical Center on June 15, 2017 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)